Durect (DRRX) submits NDA for POSIDUR, a non-opioid, long-acting local anesthetic for the...

|About: Durect Corporation (DRRX)|By:, SA News Editor

Durect (DRRX) submits NDA for POSIDUR, a non-opioid, long-acting local anesthetic for the treatment of post-surgical pain. The company, which is also developing an abuse-resistant form of oxycodone, notes that non-opioid options for the management of pain post-surgery can hasten recovery and shorten hospital stays.